Era – Michael Neidorff (1996–2022)
Peak Quarterly Performance: $535 million (Q2 2021)
Annual Performance: Maintained profitability
Main Drivers: Pharmacy benefit manager legal settlements; COVID-19 utilization spikes
Era – Sarah London (2022–Present)
Peak Quarterly Loss: $6.6 billion (Q3 2025)
Peak Annual Performance: $6.7 billion net loss (Full-Year 2025)
Main Drivers: Federal Medicaid funding cuts; asset write-downs
Why is Sara London still the face of this company if she has cost the company Billions??